TITLE

Haemacure sells assets to Angiotech Pharma

PUB. DATE
March 2010
SOURCE
Medical Device Daily;3/23/2010, Vol. 14 Issue 55, p6
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the authorization obtained by Haemacure from the Superior Court of the Province of Quebec to sell its assets to Angiotech Pharmaceuticals, a secured creditor of the company.
ACCESSION #
48772668

 

Related Articles

  • FINANCINGS ROUNDUP.  // BioWorld Today;6/4/2009, Vol. 20 Issue 106, p4 

    This section offers news briefs related to the financial status of pharmaceutical companies. Biovail Corp. announced that it will provide up to $200 million aggregate principal amount of its senior convertible notes in a private offering to qualified institutional buyers. Thallion...

  • Financings roundup.  // Medical Device Daily;5/5/2009, Vol. 13 Issue 85, p3 

    The article offers updates on financing in the medical device industry. Pulse Systems has reported that it has closed an $8.5 million credit facility through the Structured Finance Group at Fifth Third Bank. Specialty bio-therapeutics company Haemacure has entered into a term sheet with...

  • FINANCINGS ROUNDUP.  // BioWorld Today;5/5/2009, Vol. 20 Issue 85, p5 

    This section offers news briefs related to financing in the pharmaceutical industry. A senior secured bridge loan was approved by Haemacure Corp. and Angiotech Pharmaceuticals Inc. A private allocation of common stock shares were completed by Kamada Ltd. to a group of investors including UDT Med...

  • OTHER NEWS TO NOTE.  // BioWorld Today;4/8/2010, Vol. 21 Issue 67, p2 

    This section offers news briefs concerning the biotechnology industries. An agreement for additional nondilutive financing has been approved by both Ambrilia Biopharma Inc. and its subsidiary, Cellpep Pharma Inc. A contract to provide genetically modified animals was renewed by GenOway SA. All...

  • Angiotech Pharmaceuticals files for bankruptcy protection.  // Medical Device Daily;1/31/2011, Vol. 15 Issue 20, p4 

    The article unveils the plan of Angiotech Pharmaceuticals to file for bankruptcy protection under the Companies' Creditors Arrangement Act of Canada.

  • Financings Roundup.  // BioWorld Today;2/10/2011, Vol. 22 Issue 28, p2 

    The article reports on the agreement reached by Vancouver, British Columbia-based Angiotech Pharmaceuticals Inc. with the stockholders to extend deadlines outlined in a recapitalization support deal signed on October 29, 2010.

  • ENCOURAGING RESULTS FROM RHEUMATOID ARTHRITIS STUDY.  // Worldwide Biotech;Dec2000, Vol. 12 Issue 12, p6 

    Focuses on the results of a clinical study conducted by Angiotech Pharmaceuticals Inc. which used Micellar Paclitaxel for the treatment of patients with rheumatoid arthritis. Reports that Vancouver, British Columbia-based Angiotech Pharmaceuticals, Inc. has announced results from its Phase 1...

  • Guarded surgical knives designed to maintain sharpness over time. Groves, Nancy; Woodard, Lawrence // Ophthalmology Times;10/15/2008, Vol. 33 Issue 20, p41 

    The article evaluates the new guarded surgical knives from Angiotech.

  • Financings roundup.  // Medical Device Daily;4/26/2011, Vol. 15 Issue 80, p6 

    The article reports that Angiotech Pharmaceuticals will extend the maturity of the outstanding amount of its 7.75% senior subordinated notes.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics